{"name":"CMC Ambroise Paré","slug":"cmc-ambroise-par","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"inert tablet","genericName":"inert tablet","slug":"inert-tablet","indication":"Clinical trial control arm","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Bronchial fibroscopy","genericName":"Bronchial fibroscopy","slug":"bronchial-fibroscopy","indication":"Diagnosis of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and lung cancer","status":"phase_2"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"CT-P13","genericName":"CT-P13","slug":"ct-p13","indication":"Rheumatoid arthritis","status":"phase_3"}]}],"pipeline":[{"name":"inert tablet","genericName":"inert tablet","slug":"inert-tablet","phase":"marketed","mechanism":"An inert tablet contains no active pharmaceutical ingredient and produces no pharmacological effect.","indications":["Clinical trial control arm","Placebo comparator in randomized controlled trials"],"catalyst":""},{"name":"Bronchial fibroscopy","genericName":"Bronchial fibroscopy","slug":"bronchial-fibroscopy","phase":"phase_2","mechanism":"Bronchial fibroscopy is a diagnostic procedure that uses a flexible tube with a camera and light to visually examine the airways and lungs.","indications":["Diagnosis of respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and lung cancer"],"catalyst":""},{"name":"CT-P13","genericName":"CT-P13","slug":"ct-p13","phase":"phase_3","mechanism":"CT-P13 is a biosimilar of infliximab that binds to tumor necrosis factor-alpha (TNF-α) to reduce inflammatory signaling.","indications":["Rheumatoid arthritis","Crohn's disease","Ulcerative colitis","Ankylosing spondylitis","Psoriatic arthritis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":3,"phaseCounts":{"marketed":1,"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}